Cargando…
An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management
BACKGROUND: Pre-eclampsia/eclampsia is one of the most common causes of maternal and perinatal morbidity and mortality in low and middle income countries. Magnesium sulfate is the drug of choice for prevention of seizures as part of comprehensive management of the disease. Despite the compelling evi...
Autores principales: | Smith, Jeffrey Michael, Lowe, Richard F, Fullerton, Judith, Currie, Sheena M, Harris, Laura, Felker-Kantor, Erica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570392/ https://www.ncbi.nlm.nih.gov/pubmed/23383864 http://dx.doi.org/10.1186/1471-2393-13-34 |
Ejemplares similares
-
Prevention and management of severe pre-eclampsia/eclampsia in Afghanistan
por: Kim, Young Mi, et al.
Publicado: (2013) -
Efficacy of Magnesium Sulfate on Maternal Mortality in Eclampsia
por: Padda, Jaskamal, et al.
Publicado: (2021) -
Clinical pharmacokinetic properties of magnesium sulphate in women with pre‐eclampsia and eclampsia
por: Okusanya, BO, et al.
Publicado: (2015) -
Quality of care in early detection and management of pre-eclampsia/eclampsia in health facilities in Afghanistan
por: Ansari, Nasratullah, et al.
Publicado: (2019) -
Health System Barriers to Access and Use of Magnesium Sulfate for Women with Severe Pre-Eclampsia and Eclampsia in Pakistan: Evidence for Policy and Practice
por: Bigdeli, Maryam, et al.
Publicado: (2013)